Ivacaftor + Tezacaftor OverviewTezacaftor, also known as VX-661, is a drug approved by the FDA to treat some cases of cystic fibrosis. In 2018, the FDA approved a combination of ivacaftor and tezacaftor; the manufacturer announced a list price of $292,000 per year. The combination of ivacaftor and tezacaftor is being sold as Symdeko. Contents 1 Mechanism of action 2 Properties 3 Clinical trials 4 References Mechanism of action Tezacaftor helps move the CFTR protein to the corr...
Read more Ivacaftor + Tezacaftor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tezacaftor
Recent Ivacaftor + Tezacaftor Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Ivacaftor + Tezacaftor
- Tablet, Tablet: 150mg,n/a + 150mg, 100mg, 75mg,n/a + 75mg, 50mg
Drugs with one or more similar ingredients: (5 results)
- SYMDEKO Ivacaftor + Tezacaftor
- KALYDECO Ivacaftor1 discussion
- ORKAMBI Lumacaftor + Ivacaftor